Quarterly Earnings

Operational failures at a key Texas plant and a sudden drop in chlorine demand force chemical giant Olin Corp. to drastically cut its Q4 earnings forecast.

With its Q4 earnings approaching, all eyes are on Federal Realty to see if its premium retail strategy can sustain its record dividend amid market shifts.

The medtech firm's preliminary results show a Q4 revenue uptick but miss yearly estimates, signaling a stabilizing but cautious path forward for 2026.

A major customer delay impacts Ceragon's Q4 revenue, but the company projects significant growth in 2026, banking on a strong backlog and new markets.

Sana Biotechnology prepares for its pivotal J.P. Morgan update, balancing groundbreaking diabetes data against a ticking financial clock and fierce competition.

As legacy brand Hamilton Beach heads to a major conference, its high-stakes pivot from kitchen gadgets to health tech will be under the microscope.

With a major acquisition and a volatile stock, all eyes are on ServiceNow's Jan 28 results to prove its AI strategy is delivering real financial growth.

Following a reverse stock split and rebrand, Golf Entertainment Group (GLFE) uplists to the OTCQB exchange, signaling a strategic push for new capital.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

NVIDIA CEO Jensen Huang wins the 2026 IEEE Medal of Honor, a nod to his visionary work that sparked an AI revolution and a $5 trillion empire.

Alerus Financial is set to release its Q4 results, capping a year of strategic growth. Investors watch to see if its unique model can sustain momentum.

With a year of record growth and major acquisitions, all eyes are on AHR's Q4 results to see if its strong momentum will carry into 2026.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

With record Q3 earnings and strong analyst ratings, Red Violet is set to present its identity intelligence growth strategy at the prestigious Needham conference.

Fresh off a massive 240% revenue surge, Nutex Health prepares to showcase its micro-hospital model and physician-led strategy to top global investors.